Marc Schegerin
Director of Finance/CFO bei MORPHIC HOLDING, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Marc Schegerin is currently an Independent Director at SQZ Biotechnologies Co., Chief Financial & Operating Officer at Morphic Therapeutic, Inc., and Chief Operating & Financial Officer at Morphic Holding, Inc. Previously, he worked as a Program Director at Biogen, Inc. from 2009 to 2013, a Director at Citigroup, Inc. from 2016 to 2018, a Senior Director at SAGE Therapeutics, Inc. from 2013 to 2014, and as the Chief Financial Officer, Treasurer & Head-Strategy at ArQule, Inc. from 2019 to 2020.
He obtained his undergraduate degree from Tulane University (Louisiana), a doctorate from Dartmouth Medical School, an MBA from Tuck School of Business at Dartmouth, and another undergraduate degree from Harvard University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
0,07% | 16.01.2024 | 37 460 ( 0,07% ) | 1 Mio $ | 31.03.2024 |
| 31.12.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Marc Schegerin
| Unternehmen | Position | Beginn |
|---|---|---|
| MORPHIC HOLDING, INC. | Director of Finance/CFO | 06.04.2020 |
| SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 23.10.2020 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director of Finance/CFO | 01.04.2020 |
Ehemalige bekannte Positionen von Marc Schegerin
| Unternehmen | Position | Ende |
|---|---|---|
| ARQULE, INC. | Director of Finance/CFO | 01.01.2020 |
| CITIGROUP INC. | Director/Board Member | 01.04.2018 |
| SAGE THERAPEUTICS, INC. | Director/Board Member | 01.01.2014 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Marc Schegerin
| Harvard University | Undergraduate Degree |
| Tulane University (Louisiana) | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| CITIGROUP INC. | Finance |
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
